Category

Client news

Launches And Exits: Magic Pony, BleepBleeps and So-Sure

By | Client news, Entrepreneurs, Investor and VC News, Startups | No Comments

It’s been a great start to the summer of 2016! Two clients launched new products and another was acquired by Twitter for $150 million. We’re proud to work with this great group of entrepreneurs in IoT, insurance tech and machine learning. In the acquisition department, Magic Pony Technology, a stealth European tech company was acquired by Twitter in June. Magic Pony’s technology uses neural networks to improve images. According to a TechCrunch article the acquisition will bolster Twitter’s strategy to build it’s machine learning muscle and potentially improve how it delivers photos and videos across its apps. “Machine learning is increasingly at the…

Read More

Lodgify Closes 1.4 Million Funding Round

By | Client news, Entrepreneurs, investors, Startups

We recently helped our client Lodgify close their new €1.4 M funding round with Nauta Capital and other existing investors including Chris Hitchen, HOWZAT Partners and Roland Zeller. Lodgify has raised a total of €2 M to date to help rental owners and property managers generate more direct bookings and become less dependent on online travel agencies like Airbnb. Lodgify provides website builder software to enable vacation rental owners to build their own branded websites. In a recent interview with TechCrunch, Dennis Klett, CEO & Co-founder, Lodgify, said the problem is that most vacation rental owners do not have a…

Read More

Elasmogen Spins Out Of The University Of Aberdeen

By | Biotech, Client news, Investor and VC News, investors, Life Sciences

In spin out news, we advised Elasmogen on a variety of corporate and commercial matters in connection with its spin out from the University of Aberdeen. Elasmogen is a biologics drug discovery company that specialises in antibody-like proteins called soloMER. Our legal team advised and negotiated on a variety of corporate, commercial and IP agreements, including, a subscription and shareholders’ agreement, patent licence agreements, material transfer, facilities and management and secondment agreements.

Read More

The New Seed Round

By | Entrepreneurs, Investor and VC News, investors, Partner Insight

In January 2016, Tech.eu reported there was a massive uplift of seed and series A rounds across Europe.  According to the research, the biggest increases were seen at €500K or lower (pre-seed or seed) and in rounds between €1M and €5M. Tech.eu reports that compared to one year ago, deals tripled in this bracket  –  from two to 76 in 2016. At JAG Shaw Baker, this is exactly what we’ve been seeing over the past several years — a proliferation of small Seed rounds between €150K and €500K. In addition, the two other trends from our vantage point are a shift in…

Read More

Client News: M&A, IP And Partnerships

By | Client news, Entrepreneurs, Investor and VC News, investors, M&A, Startups

From an M&A deal to Condé Nast to an interesting intellectual property matter for one of the oldest cutlery companies in Europe, here’s a short round up of some of our client’s success and news: Partnerships: For the second time in 2016, our client TransferWise has joined forces with a bank. Earlier this year it was Estonia’s largest bank LHV. This time it was a German FinTech start up, Number26 backed by Peter Thiel. Number 26 is considered to be Europe’s first mobile bank. TransferWise and Number26 have teamed up to give Number26 customers in-app access to a cheap international money-transfer service. Number26’s new service…

Read More

New Location-Based App To Help Syrian Refugees And Connect Aid Organizations

By | Client news, Pro Bono, Startups

In the midst of the refugee crisis, everyone talks about doing something or contributing in some way. Last week, a group of global leaders met in London to pledge $10 M in aid for the Syrian refugee crisis and at the same time last week, Shelley Taylor, CEO of Trellyz, launched the Refugee Aid app. According to the Huffington Post, the location-based app is a place for refugees to find information on aid, connect with aid organisations and get the support they need. It’s also the place where NGOs and charities can share their resources with refugees and deliver aid…

Read More

Learn The Ins And Outs Of Funding And Financing At Our 4YFN Legal Workshop

By | Events, Startups

If you’re a high-growth start-up headed down to Barcelona for Mobile World Congress, Feb 22 – 25, 2016, then you won’t want to miss our legal workshop at 4 Years From Now (4YFN). The workshop, Break on through to the other side: A legal cheat sheet for funding and financing, is hosted by our two co-founders, Tina Baker and James Shaw. This 45-minute workshop will look at the state of funding in the EU and what the firm sees as trends in legal deals from our perspective. Our co-founders, Tina and James, will then talk about three basic things start-ups should have buttoned down…

Read More

Poised To Win: Our Clients Makes Forbes 30 Under 30 Europe List.

By | Client news, Investor and VC News, Startups

It’s nice when our clients succeed and even nicer when they make “best of” lists – especially when it’s Forbes 30 Under 30 Europe list. This new version of the original 30 Under 30 list, looked at 300 of the young leaders in 10 industry sectors in Europe. So while the trumpets are still sounding, we wanted to give them a shout. In the world of finance, our client Index Ventures’ Ophelia Brown-Finance and Berlin-based Point 9 Capital’s Nicolas Wittenborn proved their savvy and strategy could spot the start-ups with staying power. On the technology front, we saw Alex Klein, Kano; George Burgess,…

Read More

Morphogen-IX Raises £1.5M From Index Ventures

By | Biotech, Client news, investors, Startups

Cambridge-based Morphogen-IX just raised a £1.5 seed round led by Index Ventures. The company is a spin-out from Cambridge University which is working on a treatment for pulmonary arterial hypertension (PAH) which affects about 6,500 people in the UK alone. PAH is caused by the narrowing of blood vessels that lead from the heart to the lungs. When these arteries narrow, it becomes harder for the heart to pump blood through to the lungs, leading to breathlessness and heart failure. The round also included investment from Cambridge Innovation Capital and Cambridge Enterprise Seed Funds. The company says it’s dedicated to developing a therapy that will…

Read More

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.

Close